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ABSTRACT 
The development of the nervous system is a time-ordered and multi-stepped process that 
requires neural specification, axonal navigation and arbor refinement at the target 
tissues. Previous studies have demonstrated that the transcription factor Zic2 is necessary and 
sufficient for the specification of retinal ganglion cells (RGCs) that project ipsilaterally at the 
optic chiasm midline. Here, we report that, in addition, Zic2 controls the refinement of eye-
specific inputs in the visual targets by regulating directly the expression of the serotonin 
transporter (Sert) which is involved in the modulation of activity-dependent mechanisms during 
the wiring of sensory circuits. In agreement with these findings, RGCs that express Zic2 
ectopically show defects in axonal refinement at the visual targets and respond to 
pharmacological blockage of Sert while Zic2-negative contralateral RGCs do not. These results 
link, at the molecular level, early events in neural differentiation with late activity-dependent 
processes and propose a mechanism for the establishment of eye-specific domains at the visual 
targets.  
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INTRODUCTION 
Sense organs are responsible for the perception of the surrounding environment. During the 
development of the nervous system sensory organs have to connect to the appropriate target 
areas in the brain in order to function normally. The visual system has long been an ideal model 
system for understanding how development sculpts the organization of sensory circuits. In the 
visual system of mammals, retinal ganglion cells (RGCs) from each eye diverge at the optic 
chiasm midline to send axonal projections to the main visual targets —the thalamic lateral 
geniculate nucleus (LGN) and the superior colliculus (SC)— at both sides of the brain. In the 
mouse, most visual fibers cross the midline (contralateral) except for a few axons that arise from 
the peripheral ventrotemporal (VT) region of the retina that avoid the midline and project 
instead to the same side of the brain (ipsilateral) (Erskine & Herrera, 2007).  
 To maintain positional information of the visual fields and allow binocular vision, the 
final projection pattern of visual fibers at the targets follows two remarkable features: i) 
topography along the anteroposterior and the lateromedial axis and ii) eye-specific segregation 
of ipsilateral and contralateral axons (Chapman & Stryker, 1993; Chapman et al, 1996; 
Godement et al, 1984; Huberman et al, 2008; McLaughlin et al, 2003). At birth, when RGC 
axons reach the visual targets, they initially invade the entire SC and LGN (McLaughlin et al, 
2003; Sretavan et al, 1988) but after a precise refinement process, the topographic and eye-
specific projection pattern are well defined around two weeks after birth.  
 The molecular program that controls early guidance events of retinal axons at the optic 
chiasm has been described clearly. The transcription factor Zic2 is expressed in uncrossed 
(iRGCs) but not in crossed (cRGCs) ganglion cells, and is necessary and sufficient to control 
the expression of the guidance receptor EphB1 (Garcia-Frigola et al, 2008; Herrera et al, 2003). 
Glial cells at the optic chiasm express EphrinB2, an EphB1 ligand, and the interaction of these 
two membrane proteins mediates the axonal repulsive response of ipsilateral axons at the 
midline (Williams et al., 2003).  
 The molecular mechanisms governing the subsequent steps that visual fibers follow to 
establish the final projection pattern at their targets are starting to be elucidated. The 
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establishment of topographic maps in both ipsi- and contralateral fibers is mediated by the 
tyrosine kinase receptors EphAs and their ligands, the ephrinAs. Mice lacking EphA/ephrinA 
signaling show defects in axonal mapping at the superior colliculus and the thalamus. Mutations 
in the transmembrane protein, Ten_m3, or in the multi-domain protein Phr1 also lead to defects 
in the mapping of RGC axons. However, none of these molecules are differentially expressed in 
iRGC or cRGCs and consequently the segregation of ipsi- and contralateral fibers in all these 
mutant mice is not affected (Culican et al, 2009; Leamey et al, 2007; Pfeiffenberger et al, 2005).  
 In contrast, the refinement of retinal axons is perturbed when neural activity is 
manipulated. Thus, in mice that lack ß2-subunits of the neuronal nicotinic acetylcholine 
receptor, or in ferrets that receive intraocular injections of epibatidine, stage II spontaneous 
waves are abolished and although axons project to the correct retinotopic location in the targets, 
they form diffuse axonal arborizations and ipsi- and contralateral processes do not segregate 
properly (Penn et al, 1998; Rossi et al, 2001). In addition, when serotonin signaling, a well-
characterized pathway involved in the modulation of neural activity (Edagawa et al, 2001; 
Gaspar et al, 2003; Gu & Singer, 1995; Mazer et al, 1997; Sarnyai et al, 2000; Sodhi & Sanders-
Bush, 2004), is genetically or pharmacologically altered axon refinement and proper axonal 
arborization are disrupted in the visual and in other sensory systems (Arce et al, 1995; Bastos et 
al, 1999; Butt et al, 2002; Gonzalez et al, 2008; Rhoades et al, 1993; Salichon et al, 2001; Upton 
et al, 2002; Upton et al, 1999; Xu et al, 2004).  
 Despite the fact that the formation of the visual system in mammals has served as a model 
for studying axonal navigation at the midline and the coupling of neural sensory inputs in the 
targets, the molecular connection between both processes has been poorly investigated. Here, 
we report that the transcription factor Zic2 regulates directly the expression of the serotonin 
transporter (Sert) in iRGCs to refine eye-specific projections in primary visual targets. These 
results reveal that the same transcription factor that controls axon guidance in an intermediate 
target also regulates activity-dependent refinement events at the final targets. 
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 RESULTS 
Zic2 and Sert are co-expressed in ipsilateral RGCs 
To search for Zic2 target genes we compared the gene expression profiles of VT retinal 
segments of embryonic day E16.5 WT and Zic2 mutant embryos (Zic2kd/kd) (Nagai et al, 2000). 
Only seven probe-sets fulfilled the restrictive criteria applied to identify bona fide targets of 
Zic2 (Figure 1; for further details in microarrays results see Suppl. Figure S1). The only two 
down-regulated genes in the list were the neural precursor cell-expressed, developmentally 
down-regulated gene 9 (Nedd9/HEF1) and the serotonin transporter (Sert; encoded by slca4). 
Nedd9/HEF1 is a scaffolding protein in the integrin signalling pathway involved in cell 
adhesion dynamics (O'Neill et al, 2000) and may represent an interesting candidate target gene 
for further study. Here, we focus on Sert, an integral membrane protein responsible for the 
efficient uptake of serotonin from the extracellular space. This was the most down-regulated 
gene in our analysis (-3.4-fold).  
To evaluate the relationship between Zic2 and Sert we performed double staining, 
combining immunohistochemistry against Zic2 and in situ hybridization for Sert transcripts, on 
retinal cryosections from E16.5 mouse embryos. We found that both genes were co-expressed 
by the same cells in the most peripheral VT segment of the retina (Figure 2A), the location of 
iRGCs. To investigate whether Sert, like Zic2, is expressed in iRGCs and not in cRGCs, we 
performed immunostaining for Sert in semi-intact whole-mount preparations of the ventral 
diencephalon containing the entire optic chiasm region. Sert staining was clearly detectable in 
retinal axons turning ipsilaterally at the optic chiasm whereas Sert-positive retinal axons 
crossing the midline were not observed (Figure 2B). This suggests that Sert is expressed 
specifically in iRGCs and not in both iRGCs and cRGCs as thought previously (Upton et al., 
1999). 
 Next, we compared the temporal expression patterns of Zic2 and Sert at different 
developmental stages. As described previously, Zic2 expression first appeared in the peripheral 
VT segment at E14.5 (Herrera et al, 2003). Consistent with Zic2 expression Sert mRNA was 
detected in the VT retina at this age. At E16.5, when the expression of Zic2 peaked in the VT 
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retina, Sert mRNA also was expressed highly in a domain identical to that of Zic2.  At P0, the 
expression of both genes was found at the very periphery of the VT retina, and by P4 and later 
stages both molecules were undetectable (Figure 2C). The coincidental spatiotemporal 
expression of Zic2 and Sert in the mouse retina, together with the expression of Sert in 
ipsilateral but not in contralateral RGC axons, make this gene an excellent candidate as a Zic2 
downstream effector molecule.  
 
Zic2 is necessary and sufficient to induce the expression of Sert 
To further test whether Zic2 is required for Sert expression in the VT region of the retina, we 
examined Sert mRNA levels in Zic2 hypomorphic mutant mice (Zic2kd/kd). These mice die 
around E17.5 and display barely detectable levels of Zic2 (Herrera et al., 2003). We therefore 
examined Sert mRNA expression at E16.5 in Zic2kd/kd and wild-type littermates when both Zic2 
and Sert expression levels peak in the retina (Figure 2C). Sert mRNA levels were highly reduced 
in the VT retina of Zic2kd/kd embryos compared to WT littermates (Figure 3A). These data 
indicate that Zic2 expression in the developing neural retina is necessary for the expression of 
Sert in iRGCs.  
 Next, we assessed whether Zic2 is sufficient to induce Sert expression in vivo. Specific 
primers were designed to detect Sert mRNA in mouse embryonic retinas by quantitative RT-
PCR (qRT-PCR). To validate the primers dorsonasal (DN) and VT retinal segments were 
dissected out from E16.5 WT embryos and endogenous levels of Sert mRNA were measured. 
VT segments showed an increase of around 3.5-fold in Sert mRNA levels compared to segments 
from the DN region of the retina (Figure 3B). Using the highly efficient in utero electroporation 
protocol developed in our lab (Garcia-Frigola et al., 2007; Garcia-Frigola et al., 2008), 
mammalian expression vectors containing EGFP (pCAG-EGFP) or/and Zic2 (pCAG-Zic2) 
coding sequences were ectopically introduced into RGCs of the center of the retina at E13.5 
One or three days after electroporation, the targeted central portions of the retina were dissected 
out and Sert mRNA levels measured by qRT-PCR. Central retinas co-electroporated with 
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pCAG-Zic2 and pCAG-EGFP (Zic2/EGFP) and collected 24 h or 72 h after electroporation 
showed a significant increase of 2.0-fold and 2.5-fold respectively in the levels of Sert mRNA 
compared to samples electroporated with pCAG-EGFP alone (Figure 3B). Together these 
results indicate that, in vivo, Zic2 is necessary and sufficient to induce Sert expression in the 
mouse retina.   
 
Zic2 directly activates Sert transcription  
To determine if Sert is a direct transcriptional target of Zic2, we investigated whether this 
transcription factor activates Sert regulatory sequences. In order to find common mechanisms 
for the regulation of Sert expression conserved through evolution, we used the Vista browser to 
align sequences upstream of the 5’UTR of the Sert gene from six different mammalian species 
(human, monkey, dog, horse, rat and mouse) (Figure 4A). We found a 130 bp fragment 
immediately upstream of the transcriptional start site (TSS) (Bengel et al, 1997) that was highly 
conserved. Interestingly this fragment contained fundamental information to drive transcription, 
including a TATA-like motif, a cyclic-AMP response element motif, a CG-rich sequence and 
several potential binding sites for transcription factors including Gli (Figure 4A).  
  To study the potential capacity of Zic2 to activate Sert transcription, the 130bp 
conserved sequence (putative Sert promoter region) was amplified by PCR, cloned into a 
luciferase reporter plasmid (pGL3-basic), and used for luciferase assays in 293HEK cells. The 
transfection of the empty pGL3-basic plasmid, plus the empty pCAG plasmid or a mammalian 
expression vector containing the full-length Zic2 sequence (pCAG-Zic2), all resulted in basal 
luciferase activity. When pGL3 bearing the putative sert promoter region (pGL3-Sertpromoter) 
was co-transfected with an empty pCAG plasmid luciferase activity above the basal level was 
detected, confirming the previously reported transcriptional activity of this region (Heils et al, 
1998). When pCAG-Zic2 was transfected in combination with the pGL3-Sertpromoter into 
293HEK cells the luciferase levels increased more than 7-fold compared to the levels from the 
pGL3-Sert promoter and the empty pCAG plasmid. This demonstrates that Zic2 is able to bind 
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to this 130 bp-basic sert promoter region and activate transcription (Figure 4B). We also tested 
the activity of the TATA-like domain together with the GC rich domain. However, this 
sequence alone was not able to augment basal luciferase activity in either the presence or 
absence of Zic2. Thus, the rest of the elements in the 130 bp-fragment located upstream of the 
sert TSS are essential to induce transcription (data not shown).  
Although the molecular mechanism of Zic gene-regulatory function is poorly 
understood, with few available in vivo-validated DNA binding sequences, Zic genes are known 
to bind to Gli sites (Mizugishi et al, 2001). Thus, in order to further characterize the domain 
where Zic2 is binding inside the conserved 130bp sert promoter, we mutated the Gli binding 
site (Gli-BS). This resulted in a significant reduction in the activation of the sert promoter 
(Figure 4B). However, the basal activity of the promoter also was decreased. To investigate if 
this reduction in basal activity could account for the decreased activation by Zic2 we created 
two independent mutations in the sert promoter that also produced significant reductions in 
basal activity. However, neither of these mutations changed the ability of Zic2 to activate the 
sert promoter (Figure 4B). This suggests that Zic2 interacts specifically with the Gli-BS.  
 Given that in 293HEK cells Zic2 increases the luciferase activity driven by the 
conserved region of the sert promoter, we determined whether Zic2 binds to this Sert regulatory 
sequence in the retina in vivo. Chromatin immunoprecipitation assays (ChIP) were carried out 
using anti-Zic2 specific antibodies and VT chromatin from VT retinal segments of E16.5 WT 
mouse embryos. Primers flanking the 130 bp sert promoter region were used for PCR 
amplification. The ChIP assays confirmed the specific binding of Zic2 to the 130 bp sequence 
located immediately upstream of the sert TSS. No PCR product was detected in the negative 
control using primers designed to an adjacent region upstream of the conserved promoter region 
(1Kb upstream of the sert TSS). As a positive control, an anti-Acetyl-Histone3 (AcH3) antibody 
was used (Figure 4C). These results demonstrate that Zic2 is able to regulate the expression of 
Sert in iRGCs in vivo by direct binding to its promoter region.  
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RGCs that ectopically express Zic2 project in the contralateral domain of visual targets. 
The role of the serotonin signaling pathway, and more specifically SERT, in visual system 
development had been characterized previously. Mice that lack SERT or that have been treated 
with SERT inhibitors exhibit defects in the eye-specific refinement process of ipsilateral RGC 
axons (Salichon et al, 2001; Upton et al, 1999), an alteration that we have also confirmed 
(Supplemental Figure S2). Based on these findings and given that Zic2 controls Sert expression 
in iRGCs, we decided to examine whether Zic2 plays a role in refinement at the visual targets.  
 Zic2kd/kd mice die at embryonic stages and a conditional approach to remove Zic2 
specifically in the eye and analyze the projection pattern of iRGCs is not feasible because the 
lack of Zic2 in the retina causes the elimination of the ipsilateral projection (Herrera et al., 
2003). Taking advantage of our previous observation that ectopic expression of Zic2 in the 
central retina induces the expression of Sert (Figure 3B), we took a gain-of-function approach 
instead. Plasmids bearing EGFP, as a control, or Zic2 plus EGFP (Zic2/EGFP) coding 
sequences were expressed ectopically in RGCs from the center of the retina by in utero 
electroporation at E13.5. We analyzed the projection pattern of these targeted-axons in both the 
dLGN and SC in P15 mice when the axonal refinement/segregation process is complet (Figure 
5). In order to label the endogenous ipsilateral and contralateral projections at the visual targets, 
electroporated mice were monocularly injected with an axonal tracer (Cholera toxin subunit B 
(CTB)-Alexa-Fluor 594).  
 Axons expressing EGFP alone were found projecting inside the territory occupied 
normally by contralateral axons in both dLGN and SC (Figure 5). As reported previously, 
ectopic expression of Zic2/EGFP in the center of the retina caused approximately 40-45% of 
targeted RGCs to switch laterality and project ipsilaterally (Garcia-Frigola et al, 2008; Petros et 
al, 2009). The analysis of these ectopic Zic2-positive axons revealed that they were able to find 
their way to the ipsilateral dLGN and SC in spite of being in the wrong hemisphere. 
Furthermore, although their axonal arborization was deficient and neurite processes were poorly 
elaborated, they were all found in the territory normally occupied by contralateral axons (Figure 
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5). This demonstrates that, although their laterality at the chiasm is altered, central RGCs 
expressing ectopically Zic2 still project into the contralateral eye-specific domain as it 
corresponds to their “central-contralateral” position in the retina.  
 
RGCs that ectopically express Zic2 do not refine properly in the SC  
Although RGCs expressing Zic2 ectopically projected into contralateral domains, their 
projection phenotype was abnormal. To further investigate this issue, and since alterations in the 
serotonin pathway produces more evident phenotypes in the SC than in the dLGN, we studied 
the projection of targeted axons in the SC of electroporated animals. We first characterized the 
projection pattern of central RGCs during development. Brains of mice electroporated at E13.5 
with EGFP alone were sacrificed at three different time points, P0, P4 and P15, dissected out 
and sectioned sagitally to evaluate the rostro-caudal distribution of the targeted projections. At 
P0 and P4, EGFP positive axons had reached the most caudal area of the colliculus. By P15, 
targeted axons had already refined and formed complex and elaborated arbors in the medial area 
of the colliculus contralateral to the electroporated eye (Figure 6). EGFP positive axons were 
not found in the ipsilateral SC.  
 Next, we analyzed the projections of Zic2/EGFP electroporated axons. In this case 
targeted axons were always found in both the contralateral and the ipsilateral side of the 
colliculus. At P0 and P4, Zic2/EGFP axons had reached the caudal areas of the SC, similar to 
when only EGFP is electroporated. However, at P15 defects were seen in EGFP/Zic2 positive 
axons in both the ipsilateral and contralateral SC. In the ipsilateral SC EGFP/Zic2 axons 
remained in caudal areas instead of in the central region appropriate to the location of their cell 
bodies in the retina. In addition, the terminal fields of these neurons were diffuse showing a 
deficient elaboration of axon arbors (Figure 6). In the contralateral SC, most EGFP/Zic2 
electroporated axons projected properly into their correct termination zone in the medial SC. 
However, we found consistently that a small proportion were located ectopically in caudal areas 
(Figure 6r). Since we co-electroporated two plasmids (pCAG-Zic2 and pCAG-EGFP) it is likely 
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that axons correctly projecting and arborizing in the medial areas of the colliculus are those that 
express EGFP but do not co-express Zic2 or express it at low levels. Conversely, the axons that 
misproject into caudal areas are likely Zic2 positive fibers that had already passed the midline 
when ectopic Zic2 expression was initiated. In order to quantify the extent of this abnormal 
projection in the contralateral SC, we performed fluorescence quantifications on the caudal 
collicular area of animals electroporated with Zic2/EGFP and found a significant increase in 
fluorescence in this area compared to controls electroporated only with EGFP (Figure 6 s-u). 
This projection of Zic2-transfected axons beyond their topographically correct TZ resembles the 
projection errors caused by pharmacological or genetic alteration of serotonin levels during 
development (Bastos et al, 1999; Gonzalez et al, 2008; Ravary et al, 2003; Upton et al, 2002).  
 
Zic2-positive but not Zic2-negative RGC axons respond to pharmacological blockage of Sert 
Next we investigated whether the lack-of-refinement phenotype observed in the axons 
ectopically expressing Zic2 is due to the misexpression of Sert. In order to test this hypothesis, 
we electroporated E13.5 embryos in the central retina and waited until the mice were born. 
Then, we administered a daily dose of fluoxetine, a well known inhibitor of Sert (Wong et al, 
1995; Wong et al, 1974), until they were analyzed at P15. Fluoxetine treatment induced a 
significant change in the TZs of RGC axons electroporated with Zic2, producing a medial shift 
of the projections back to their topographically correct location (Figure 7a-c). In general, we 
also observed that after fluoxetine treatment, Zic2 positive fibers showed a more exuberant 
elaboration of axon arbors compared to Zic2 positive saline treated fibers.  
 In the contralateral SC of P15 mice electroporated with Zic2/EGFP, we focused our 
analysis in the caudal collicular areas (Figure 7d,e) that contain the axons with a defect in 
refinement. We found that in fluoxetine-treated mice the extent of aberrant axon projections 
within the caudal collicular area was reduced significantly compared with saline-treated animals 
(Figure 7 d-f). We cannot rule out the possibility that Zic2 controls other molecules that also 
participate in refinement processes at the SC. Nevertheless, the partial rescue of the Zic2 
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missexpression phenotype by blocking Sert demonstrates clearly that Zic2 upregulates Sert 
which then inhibits the proper refinement and arborization of retinal axons at the colliculus.  
 Previous reports have examined how alterations in serotonin levels affect the refinement 
of ipsilateral RGCs axons at the SC (Bastos et al, 1999; Gonzalez et al, 2008; Upton et al, 
2002). However, the phenotype of contralateral RGC axons after changing serotonin 
concentrations has not been evaluated, likely because the analysis of contralateral axons is 
technically more challenging. To investigate this issue we electroporated EGFP in central RGCs 
at E13.5 followed by treatment with fluoxetine or saline as described above. EGFP targeted 
axons project to their correct TZ, the medial portion of the colliculus and the degree of 
arborization was very similar in fluoxetine and saline treated animals (Figure 7g-i). This 
demonstrates that inhibition of Sert does not affect the refinement of cRGCs. Together with 
previous results, these findings demonstrate that Zic2 controls specifically the refinement of 
ipsilateral but not contralateral axons in the primary visual targets by controlling directly the 
expression of Sert. 
 
Zic2 modulates refinement at the SC independently of controlling laterality at the midline  
Since the stronger refinement phenotype in Zic2 electroporated animals was found in the 
ipsilateral SCs, we wanted to rule out the possibility that switching laterality at the midline 
affects axonal refinement at the targets. To address this, we expressed ectopically EphB1 in the 
central region of the retina and analyzed postnatally the retinocollicular projections. In 
agreement with previous reports, we found that ectopic expression of EphB1 resulted in 15 – 
20% of the targeted axons projecting ipsilaterally (Garcia-Frigola et al., 2008; Petros et al., 
2009). However, we found that EphB1-electroporated axons on both the ipsilateral and 
contralateral SC formed TZs in the topographically correct location (Figure 8A). This 
demonstrates that a switch in axonal laterality does not determine the eye-specific territory, 
topographic projection pattern or refinement at the target. This result also suggests that contact 
of RGCs axons with midline cues does not generate a retrograde signal that modulates the 
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projection patterns at the targets. We also found that Sert expression is independent of EphB1.  
In mice lacking EphB1 expression of Sert in the retina was maintained in a pattern 
indistinguishable from wildtype (Figure 8B).  
 Next, we asked if Sert is required for guidance at the midline. In contrast to ectopic 
expression of Zic2 or EphB1, we found that electroporation of Sert (pCAG-Sert) in central 
RGCs did not affect guidance at the midline (Figure 8D). In agreement with previous reports 
(Upton et al., 2002), we also found that Sert-deficient mice did not exhibit any alteration in the 
number of ipsilateral RGC axons (Supplementary Figure S2). This indicates clearly that Sert 
does not play a role in controlling guidance at the midline. Together these results demonstrate 
that axon guidance at the midline and refinement of ipsilateral axons in the SC are independent 
phenomena. Zic2 plays a role in both processes by activating independently different effectors: 
EphB1 to control laterality and Sert to modulate refinement at the visual targets.  
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DISCUSSION 
 
In the present study we show that the transcription factor Zic2 plays an important role in 
controlling eye-specific refinement in the SC by inducing the expression of Sert specifically in 
iRGCs. Together with previous results, this demonstrates that Zic2 determines the ipsilateral 
phenotype in the retinofugal pathway by regulating the transcription of at least two downstream 
effectors, EphB1 and Sert, which act sequentially at different steps of the maturation process in 
the visual pathway.  
 
Zic2 controls the transient expression of Sert during development 
Several days after the generation of the raphe neurons, serotonin accumulation can be detected 
in several classes of thalamic, cortical, hypothalamic and retinal neurons. These neurons do not 
express tryptophan hydroxylase (Tph) or dopa decarboxylase (Aadc), which are required for 
serotonin synthesis, or the catabolic enzymes monoamine oxidase A and B. The presence of 
serotonin in these neurons is explained by the transient expression of Sert that reuptakes 
serotonin from the extracellular space (Gaspar et al, 2003). The transcriptional network 
controlling the levels of serotonin in the raphe nuclei has been intensely studied. The 
transcription factor Pet1 is expressed in serotonergic neurons and directly activates the 
transcription of genes that are involved in the synthesis (Tph and Aadc) and uptake (Sert) of 
serotonin. However, not much is known about the regulation of the transient Sert expression in 
non-aminergic neurons. The transcriptional mechanisms controlling serotonin signaling in these 
neurons probably differ from those uncovered in the raphe nuclei, as none of the genes that 
regulate the serotonin phenotype in the raphe have been found in areas that transiently express 
Sert. The results presented here support this hypothesis and point to Zic2 as the first 
transcription factor that regulates Sert expression and serotonin homeostasis in non-aminergic 
neurons during development.  
 
Sert as a modulator of activity-dependent refinement 
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We demonstrate here that Zic2 induces directly the transcription of Sert in iRGCs. Sert is 
known to adjust the extracellular concentration of serotonin (Jennings et al, 2006; Wong et al, 
1974). Serotonin signaling plays a critical function in axonal refinement processes in several 
systems and animal models. Genetically modified mice lacking monoamine oxidase A, an 
enzyme that breaks down serotonin, exhibit severe disruptions in the barrels domains of the 
primary somatosensory cortex (Rebsam et al, 2002) as well as in eye-specific segregation in the 
dLGN and SC (Upton et al, 1999). In rodents, increased levels of serotonin prevent the 
segregation of retinocollicular axon terminals (Upton et al, 2002) and decreasing serotonin 
levels by parachlorphenyalanine treatment or by neonatal tryptophan restriction in the diet, also 
affect retinofugal fiber refinement (Gonzalez et al, 2008; Upton et al, 1999). Similarly, 
pharmacological blockade or genetic removal of Sert perturbs eye-specific refinement of retinal 
axons at the visual targets (Bastos et al, 1999) or barrels formation in the cortex (Xu et al, 
2004). 
 Since cAMP signaling is essential for the segregation of eye-specific inputs (Pham et al, 
2001; Ravary et al, 2003; Stellwagen et al, 1999) it is likely that, as in other systems, serotonin 
signaling acts in the visual system by affecting cAMP levels. Serotonin receptors (5HT1B) are 
localized in all RGCs axon terminals (Salichon et al, 2001). The 5HT1B receptor is negatively 
coupled to the adenylate cyclase 1 (AC1) via G-proteins of the Gαi subtype (Lin et al, 2002). 
AC1 is a key player in the refinement of the ipsilateral retinal projection in both the LGN and 
the SC, acting presynaptically in RGCs to modulate the reshaping of axon terminal arbors in the 
retinofugal projections and not affecting axon guidance in the traveling of retinal fibers to the 
targets (Nicol et al, 2006; Nicol et al, 2007; Plas et al, 2004; Ravary et al, 2003). In cRGCs the 
activation of the 5HT1B receptor would inhibit cAMP production in the axon terminals. 
However, retinal axons that express adequate levels of Sert can internalize extracellular 
serotonin and relieve 5HT1B-mediated inhibition, allowing the production of cAMP and 
promoting the refinement process (Supplemental Figure S3). Supporting this theory, mice 
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lacking another component of the machinery, the 5HT1B receptor, also show defects in eye-
specific segregation in the LGN and SC (Upton et al, 1999). 
Our data confirm previous reports showing that either, increasing or decreasing the 
levels of extracellular serotonin affect axon refinement in several sensory systems (Gonzalez et 
al, 2008; Rebsam et al, 2005; Upton et al, 2002; Upton et al, 1999; Xu et al, 2004). Sert null 
mice that have accumulated serotonin extracellularly show a “lack-of-refinement” phenotype 
and mice that ectopically express Sert (induced by Zic2) exhibit similar alterations in the 
refinement process. Interestingly it has been reported that rather than absolute cAMP levels, the 
appropriate balance of cAMP production and degradation is essential for retinal axon 
refinement (Nicol et al, 2007). It is thereby likely that alterations, positive or negative, in the 
levels of serotonin disturb the production of cAMP oscillations preventing axonal refinement of 
ipsilateral axons.  
 
Eye-specific layering at the targets: dependent or independent of laterality at the midline? 
A number of observations indicate that axon laterality at the midline and the establishment of 
projection patterns and eye-specific segregation at the visual targets are independent events. The 
Robo and Comm mutants in Drosophila (Karlstrom et al, 1996), the astray mutants in zebrafish 
(Wolf & Chiba, 2000), the Siamese and albino cats (Creel et al, 1982; Guillery, 1969; Kliot & 
Shatz, 1985), and the achiasmatic sheepdogs (Williams et al, 1994) show normal projection 
patterns at the final targets despite the fact that they all have alterations in the ipsi/contra ratio. 
In agreement with these observations, when we ectopically expressed EphB1 to force some 
cRGCs axons to switch laterality at the midline, they projected correctly in the topographic 
collicular area corresponding to their retinotopic position, a phenomenon similar to the situation 
previously described for the dLGN (Rebsam et al, 2009). Our data confirm that divergence at 
the midline and determination of the projection phenotype at the targets are independent events. 
However, our findings also demonstrate that these processes are not unrelated because both 
require the action of a common transcription factor, Zic2.  
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 In addition, in EphB1 null mice around 60% of the axons from the VT retina change 
laterality and are misrouted to the contralateral LGN (Williams et al., 2003). Despite the change 
in laterality, these misrouted axons target in the topographic area that corresponds to the 
ipsilateral domain but in the contralateral side and segregate perfectly from the real contralateral 
axons, forming a patch that never mingle with the endogenous contralateral projections 
(Rebsam et al, 2009). We have observed that the levels of Sert in the VT region of EphB1-/- 
mice are normal which indicates that these misrouted axons still express endogenous levels of 
Sert and argues for a role of this transporter in the segregation of VT axons even when they 
project in the wrong hemisphere.  
 
Zic2, the first transcription factor involved in the establishment of RGC axonal refinement 
We have shown that ectopic expression of Zic2 in central retina induces axons to project to 
medio-caudal areas of the SC. We have excluded the possibility that this phenotype is caused by 
a change in laterality. An alternative explanation to this finding is that Zic2 regulates some 
additional molecules involved in targeting at the colliculus. However, this is unlikely because 
ipsilateral axons, which naturally express Zic2, do not project caudally but rostrally. It seems 
more plausible that ectopic expression of Zic2 in central retina affects the refinement process of 
these neurons because the relative levels of serotonin they sense are not perfectly balanced. 
Axons from the central retina first overshoot their TZs to innervate caudal positions of the SC to 
then retract and project in central positions (Simon & O'Leary, 1992). The ectopic expression of 
Zic2 in cRGCs leads to a lack-of-refinement phenotype of their axons, a defect that is partially 
reverted after application of fluoxetine indicating, at least in part, this phenotype is caused by 
induction of Sert.  
 It is not clear whether refinement and segregation are independent processes but 
changes in serotonin levels affect both. The cRGCs that are neighboring the iRGCs arise from 
the VT retina and project to similar areas than ipsilateral fibers on the contralateral side but they 
eventually segregate from them. Based on this premise, and assuming that levels of 
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EphA/ephrinAs and other axon guidance molecules determine the final projection pattern of all 
retinal axons, it is possible that iRGCs only differentiate from cRGCs in two aspects: i/ the 
decision of avoiding the midline and ii/ the expression of molecules that permit the 
refinement/segregation process. Our results are on line with this idea because ectopic expression 
of Zic2 does not cause a change in the identity of central-contralateral cells to now project into 
the ipsilateral domain. According to this view, Zic2 would be a “master-gene” that provides the 
necessary molecules to distinguish iRGCs from cRGC in these two stages of differentiation.  
 Overall, the results presented here link, for the first time, early molecular events in axon 
guidance with late activity-dependent refinement processes and points to Zic2 as a key regulator 
of different steps during the establishment of the visual circuitry in mammals. 
 
MATERIAL AND METHODS  
 
Animals  
Mice embryos from BDF1 (DBA2 x C57/B6) WT, Zic2+/kd (Nagai et al, 2000), EphB1-/- 
(Williams et al, 2003) and Sert-/- (Bengel et al, 1998) strains were kept in a timed pregnancy 
breeding colony at the Instituto de Neurociencias (IN). Animal protocols were approved by the 
IN Animal Care and Use Committee.  
 
Microarrays analyses 
Total RNA was extracted from triplicate pools of 14-16 retinal VT segments from E16.5 WT 
and Zic2kd/kd embryos. Samples were then processed as in (Lopez de Armentia et al, 2007). The 
list of significantly changed probe sets shown in Figure 1 was obtained after filtering by signal 
intensities (20-100th percentile in the raw data), statistical significance (P<0.05, unpaired t-test) 
and fold change (>2.0) using GeneSpring GX software (Agilent Technologies, Santa Clara, 
CA). 
 
In situ hybridization and immunohistochemistry 
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In situ hybridization was performed as in (Schaeren-Wiemers & Gerfin-Moser, 1993). To 
perform fluorescent reactions TSA system (Perkin Elmer) was used following the 
manufacturer’s instructions. To generate Sert probes the following primers were used: 
ATCGTGGTCATCACTTGCATC-, GTTACACAGCATTCATGCGG-. Immunohistochemistry 
protocols were performed as in (Garcia-Frigola et al, 2008; Herrera et al, 2003). Anti-Zic2 
(Brown et al, 2003) and anti-SERT antibodies (Blakely et al, 1994) were used at 1:10000 and 
1:1000 respectively.  
 
Quantitative RT-PCR  
Retinas of E13.5 WT embryos were electroporated in utero with CAG-EGFP or CAG-Zic2 
plasmids and qRT-PCR was performed as in García-Frigola et al., 2008. 
 
Luciferase assays 
A fragment of 130bp was cloned into pGL3-Basic (Promega) (pGL3-Sert prom). Mutations in 
the CRE-like, GC-rich and Gli-binding sites were introduced by site-directed mutagenesis 
giving rise to the following sequence substitutions: GGCGGCG into GAATTCG; TGACGCA 
into GGATCCA and GGGGCCG into GAATTCG. Luciferase reporter plasmids carrying the 
corresponding mutations were named: pGL3-Gli mut, pGL3-CRE-like mut and pGL3-GC mut. 
The pCAG-Zic2 or the empty pCAG were co-expressed with the luciferase reporter plasmids. 
293HEK cells plated in 24 well-plates were co-transfected with 0.4 µg of a luciferase reporter 
plasmid (pGL3-Basic, pGL3-Sert prom, pGL3-Gli mut, pGL3-CRE-like mut or pGL3-GC mut), 
10 ng of SV40-ßgal and 0.4 µg of pCAG or pCAG-Zic2. 24 hours later cells were lysated and 
luciferase and ß-galactosidase activities measured using Luciferase Reporter and Beta-Glo 
Assay Systems (Promega) following manufacturer’s guidelines. Each sample was assayed in 
triplicate and luciferase activities were normalized using ß-galactosidase. The fold increase in 
luciferase activity was calculated as a ratio between the activity in the presence of Zic2 and the 
activity measured in the presence of the empty vector pCAG for each construct. Data was 
statistically analyzed with SPSS using student’s unpaired t-test.  
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Chip assays 
VT retinal quadrants from 2 litters of E16.5 embryos were dissected out and proteins cross-
linked to DNA in a 1% formaldehyde solution for 20 min at room temperature. Chromatin 
immunoprecipitation was carried out as described in the Upstate Biotechnology protocol. Zic2 
was immunoprecipitated using anti-Zic2 antibodies (Brown et al, 2003) and control 
immunoprecipitations were performed using anti-acetylated Histone 3 (Sanchis-Segura et al, 
2009), rabbit IgGs or no antibody. Primers used for amplification: Sert promoter: -
CTGCTGTATGTGCAGGAATG-, -CGCGCTATTTGTACTTGCGG-, Control -
GCTGGTAGTTTGTCAGTGCCC-, AGGTCCTGCTCCGTGTCACTCC-.  
 
In utero electroporation, fluoxetine treatment and CTB injections 
Electroporation experiments were carried out in BDF1 (DBA2 X C57/B6) mice. Retinal in utero 
electroporation was performed as described in (Garcia-Frigola et al, 2007). For postnatal 
analysis in the LGN and SC, electroporated pups were sacrifice and fixed at P15. Brains were 
sectioned for analysis and quantification of retinal projections in the targets. For fluoxetine 
treatment a daily injection of fluoxetine (10mg/Kg, Sigma) or saline was administered 
subcutaneously from P1 to P4, and then intraperitoneally from P5 to P15. The corresponding 
retinas were removed and flat mounted to confirm electroporation in the central retina and to 
obtain a retinal electroporation ratio (retinal electroporated area/ total retinal area). CTB 
injections were performed at P14 as in (Rebsam et al, 2009).  
 
Analysis and quantification of axonal projections in the SC 
Brains of mice whose retina was electroporated around the optic disc and the ratios of 
electroporation were comparable were used to quantify possible differences in the 
retinocollicular projections along the rostrocaudal axis of the SC. “Comparable” was defined as 
having a retinal electroporation ratio less than 12% different. Sections of the SC of equivalent 
latero-medial levels were analyzed. For each section, the rostrocaudal length of the SC was 
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divided into six portions and fluorescence intensity in a circular area of constant size inside of 
each portion in contact with the collicular surface was measured using Image J. In the cases 
where only the caudal portion of the SC was analyzed at higher magnification, only 3 
measurements were made. For each value, background fluorescence values were subtracted 
from absolute values. Then, value of absolute fluorescence was divided by the value of average 
fluorescence in the section, generating values of relative fluorescence. Data was statistically 
analyzed with SPSS using a two-way ANOVA to evaluate the interactions between side of the 
colliculus (ipsi-contra) and the position of the projection or pharmacological treatment and 
position of the projection. All images were taken using DC500 camera (Leica) coupled to a 
Leica DM 5000B microscope. For quantification of the projections at the SC pictures were 
taken with the 5x objective except for the high magnification images that were taken using 10x 
objective.  
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FIGURE LEGENDS 
Figure 1. Gene expression analysis comparing VT retinal segments from E16.5 WT and 
Zic2 mutant retinas. Hit map generated from the DNA microarray data showing the seven 
probe-sets/transcripts (6 genes) significantly altered on samples from Zic2 knock-down mice ( 
Zic2kd/kd) with fold-change larger than 2 (p<0.05, unpaired t-test). This graph was generated 
using the GeneSpring GX software. The probe-set ID (left), gene symbol, average fold change 
over triplicate microarrays (FC) and P values for each transcript are indicated. The color scale 
bar indicates up-regulation in red and down-regulation in blue. 
 
Figure 2. Spatio-temporal co-localization of Zic2 and Sert in iRGCs. 
(A) Fluorescent immunostaining against Zic2 (green) combined with in situ hybridization for 
Sert (red) performed in a coronal section from an E16.5 mouse retina shows that Zic2 and Sert 
are expressed in the peripheral ventrotemporal retina. Below each image, higher magnifications 
of the corresponding squared areas are shown. (a) Colorimetric immunostaining against Zic2 
combined with in situ hybridization for Sert demonstrate that cells expressing Sert mRNA 
(purple) are Zic2 positive neurons (brown). Black arrowheads highlight cells that are double 
positive for Zic2 and Sert mRNA. The right corner contains, a high magnification of the squared 
area. np, neural progenitors; cb, ciliary body.  Scale bar: 100µm.   
(B) (b) Scheme showing a ventral view of the diencephalon that includes the optic chiasm area. 
Black lines represent contralateral axons and red lines represent ipsilateral axons.  (c) The 
picture shows an immunohistochemistry against Sert (red) performed in a semi-intact 
preparation that contains the optic chiasm region. Sert expression is localized in ipsilateral 
axons, while axons crossing the midline are Sert-negative. on, optic nerve; ot, optic tract. Scale 
bar: 100µm.   
(C) Top panels show immunostaining against Zic2 (white arrows) in VT retinal sections from 
E12.5 (d, e) E14.5 (f, g), E16.5 (h, i), P0 (j, k), P4 (l, m) and P9 (n, o) mice. Bottom panels 
show in situ hybridization against Sert mRNA (black arrows) in the same sections. The 
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expression of both genes peaks at E16.5 and it is completely down-regulated by P4. RGCs, 
retinal ganglion cells; cb, ciliary body; np, neural progenitors. Scale bar: 100µm. 
  
Figure 3. Zic2 is necessary and sufficient for the expression of Sert in the retina 
(A) The images show coronal retinal sections from WT (a, b, c), and homozygous Zic2kd/kd (d, e, 
f) E16.5 littermate embryos. Immunostaining against Zic2 in these sections shows that it is 
expressed in the VT retina in Zic2+/+ and disappears in Zic2kd/kd embryos. In situ hybridization to 
Sert (red) in the same retinal sections demonstrates that Sert is highly downregulated in the 
absence of Zic2. Scale bars: 100µm. 
(B) The left panel shows quantitative RT-PCR analysis performed on segments from dorsonasal 
(DN) or VT E16.5 WT retinas to detect Sert mRNA. Sert mRNA levels were 3-fold higher in the 
VT than in the DN retina. The right panel shows quantitative RT-PCR comparison for Sert 
mRNA performed on central retinas of embryos electroporated at E13.5 with CAG-EGFP or 
with CAG-Zic2/CAG-EGFP plasmids and dissected 24 or 72 h after electroporation. At least 
three retinas for each condition were pooled per experiment. The average of three and five 
different experiments is shown for 24h and 72h respectively. Error bars indicate ±SEM 
(*p<0.05, student´s unpaired t-test).  
 
Figure 4. Zic2 directly regulates Sert expression.  
(A) VISTA view of the occurrence of conserved sequence domains upstream of the first sert 
exon (purple arrow). Light blue arrow indicates the consensus transcription start site of sert 
(TSS). Shown from top to bottom are human vs. mouse (H/M), monkey vs. mouse (M/M), dog 
vs. mouse (D/M), horse vs. mouse (H/M) and rat vs. mouse (R/M) sequences. The colored 
peaks (purple: coding, blue: UTR, pink: conserved non-coding regions) indicate regions of at 
least 100 bp with a conservation score of at least 75%. The pink arrow indicates a highly 
conserved peak of 130bp upstream of the TSS that has been proposed as the basal Sert promoter 
sequence. The 130bp mouse sequence of the conserved Sert promoter, including putative 
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binding sites (in different colors) for the indicated transcription factors is graphically 
represented below the VISTA comparison.   
(B) Luciferase assays to evaluate the transcriptional activity of Zic2 on the 130 bp Sert 
promoter region. After transfection of pCAG-Zic2 in 293HEK cells together with luciferase 
vectors containing the 130bp Sert promoter region, Zic2 increases the basal transcriptional 
activity of the 130 bp conserved Sert promoter more than 7-fold compared to the controls. A 
mutation in the Gli-binding sequence significantly reduces this induction. By contrast, 
mutations in the CRE-like motif or the GC-rich domain of the sert promoter had no effects on 
the induction by Zic2. The values represent means ± SEM of at least four triplicates, except for 
pGL3-GC with two triplicates (*p<0.01, student´s unpaired t-test). 
(C) ChIP assays demonstrate that Zic2 binds to the basal promoter region of Sert in the 
embryonic E16.5 VT retina in vivo. In the upper panel, primers to amplify the 130 bp Sert basal 
promoter were used while in the bottom panel control primers to amplify a 5´upstream non-
conserved sequence were used. Zic2 binds to the Sert basal promoter (black arrow) but not to 
the control sequence (black arrowhead). Anti-AcH3 antibodies were used as positive controls 
and non-specific rabbit serum as negative control (IgGs).  
 
Figure 5. Axons that ectopically express Zic2 project into the contralateral-specific 
domain in the visual targets. (a) Summary of the experimental approach used to visualize 
retinal axons at the dLGN and SC. Plasmids bearing EGFP or Zic2/EGFP were introduced in 
central RGCs by in utero electroporation at E13.5. At P14 electroporated mice were 
monocularly injected with the axonal tracer cholera toxin subunit B (CTB-Alexa594) and they 
were sacrificed one day later. Dashed-lines indicate the level of the sections. Representative 
coronal sections through the dLGN of P15 mice electroporated with EGFP (b) or with 
Zic2/EGFP (c, d) show that all targeted axons project into contralateral-specific domains. (e, f, 
g) Representative coronal sections through the SC of P15 mice electroporated with EGFP or 
with Zic2/EGFP show that all targeted axons project into contralateral-specific domains. Red-
dashed lines outline the territory occupied by axons coming from the CTB injected eye. White-
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dashed lines outline the territory occupied by axons coming from the non-injected eye. m, 
medial; l, lateral. Scale bars: 100µm. 
 
Figure 6. Axons that ectopically express Zic2 do not refine properly at the colliculus  
(a-g) Pictures show representative sagittal sections of the SC from P0, P4 and P15 mice that 
were electroporated with plasmids bearing the coding sequence of EGFP in the central retina at 
E13.5. (a) In the hemisphere contralateral to the electroporated eye EGFP positive axons 
coming from the central retina reach the caudal region of the colliculus at P0. (c) Four days 
later, at P4, although a high proportion of axons were found in the caudal collicular region, 
many of them have started to refine and arborize into more central areas. (f) By P15, all axons 
have already refined and they can be found only in central areas of the SC. (b, d, g) Pictures 
show that EGFP positive axons were not found in the ipsilateral side at any stage.  
(i-p) Pictures show representative sagittal sections of the SC from P0, P4 and P15 mice that 
were co-electroporated in the central retina at E13.5 with plasmids bearing the coding sequence 
of Zic2 and EGFP. (i, k) In the hemisphere contralateral to the electroporated eye Zic2/EGFP 
positive axons coming from the central retina reach the caudal region of the colliculus at P0 and 
P4. (o) By P15, many axons have already refined and they can be found in central areas of the 
SC. In this case, in contrast to the EGFP control, some targeted axons were detected in the 
caudal areas. (j, m, p) In the ipsilateral side of Zic2/EGFP electroporated mice, targeted axons 
were found in the caudal colliculus at all the stages, including P15. Red arrowheads highlight 
the most caudal position where targeted axons were visualized.  
 (e, n) Schematic representations of the projection phenotypes along the visual pathway 
summarize the results obtained in mice electroporated at E13.5 and analyzed at P0 and P4. (h, q) 
Schematic representation of the projection phenotype in the SC of animals electroporated with 
EGFP or Zic2/EGFP at E13.5 and analyzed at P15. (r) Quantitative comparison of fluorescence 
measurements in the contralateral colliculus of P15 mice electroporated with EGFP or with 
Zic2/EGFP at E13.5. Despite no overall significant differences were found comparing the 
axonal distribution in the sections of EGFP and Zic2/EGFP electroporated mice, it is important 
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to note the increase in the fluorescence values of the Zic2/EGFP in the most caudal point of the 
SC. (s, t) High magnification pictures of the caudal-squared areas in (f) and (o). The red-dashed 
lines delineate the caudal limit of the correct TZ according to the central location of the targeted 
RGCs in the retina. (u) Quantification of the levels of fluorescence in the caudal region of 
collicular sagittal sections (yellow circle) from P15 mice shows a significant increase in the 
amount of fluorescence in Zic2/EGFP electroporated mice compared to the controls. Data 
obtained from 6 animals and 3 sections from each animal for each condition (*p≤0.05, student´s 
unpaired t-test). (v) Quantitative analysis of fluorescence measurements in sagittal sections 
comparing contralateral versus ipsilateral P15 colliculus electroporated with Zic2/EGFP, show 
that the distribution of the projections on each side is significantly different. Error bars indicate 
±SEM. Statistical analysis was performed using a two-way ANOVA (F (5.144) position x projection 
type=20.247, p ≤0.0001). Data obtained from 4 animals, and 3 sections from each animal for each 
condition. r, rostral; c, caudal.  Scale bars: 100µm. 
 
Figure 7. Zic2-positive but not Zic2-negative axons respond to fluoxetine treatment. 
The pictures show representative sagittal sections of the SC from P15 mice that were 
electroporated at E13.5 in central retina and then treated with saline or fluoxetine from P0 to 
P15. To summarize the results, schematic representations of collicular sections are shown below 
each image. The red-dashed lines delineate the caudal limit of the correct TZ according to the 
central location of the targeted RGCs in the retina. (a, b) In the ipsilateral SC of animals 
electroporated with Zic2/EGFP, axons projected to more rostral areas in fluoxetine-treated than 
in saline-treated animals. (c) Quantitative analysis of fluorescence measurements in sagittal 
sections of colliculus electroporated with Zic2/EGFP treated with saline versus fluoxetine 
shows a significant displacement of the projection to more rostral positions after fluoxetine 
treatment (F (5.240) position x treatment= 2.86, p=0.016). Data obtained from 5 animals and 4 equivalent 
sections from each animal for each condition. (d, e) High magnification pictures of the caudal 
portion of the contralateral SC (squared area) of mice electroporated with Zic2/EGFP show that 
axons treated with fluoxetine project to more rostral areas than those treated with saline. (f) 
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Quantification of the levels of fluorescence in the caudal region of collicular sagittal sections 
(yellow circle) shows a significant decrease in the amount of fluorescence in the fluoxetine-
treated animals compared to the saline-treated (*p≤0.001, student´s unpaired t-test). Data were 
obtained from 6 animals and 3 sections from each animal for each condition. (g, h) In the 
contralateral SC of animals electroporated with EGFP, axons project in the medial region in 
both saline and fluoxetine treated mice. Since EGFP axons did not project into the ipsilateral 
side, the ipsilateral colliculi are not shown. (i) No significant differences were found after 
quantitative analysis of fluorescence measurements in sections of SCs from EGFP-
electroporated mice treated with saline versus fluoxetine. Data were obtained from 3 animals 
and 3 equivalent sections from each animal per treatment. Error bars indicate ±SEM. Statistical 
analysis was performed using a two-way ANOVA. r, rostral; c, caudal. Scale bars: 100µm. 
 
Figure 8. Zic2 controls refinement at the SC independently of controlling axon guidance at 
the midline. 
(A) Pictures show representative sections of the SC from P15 mice electroporated at E13.5 with 
CAG-EphB1 plasmids. Axons ectopically expressing EphB1/EGFP project to the medial region 
in both, the contra- and the ipsilateral SC. Schematic representations of collicular sections are 
shown below each image. Dashed lines delineate the caudal limit of the correct TZ according to 
the location of targeted RGCs in the retina. In the right panel the projection phenotypes are 
summarized. Sections from 4 different embryos electroporated with EphB1/EGFP were 
analyzed and all of them showed similar phenotypes at the colliculus. r, rostral; c, caudal;  
(B) Coronal section from an E16.5 EphB1-/- VT retina, in which an immunostaining against 
Zic2 (green) was combined with in situ hybridization to Sert (red), shows that expression of Sert 
is normal in the absence of EphB1. np, neural progenitors; cb, ciliary body.  Scale bars: 100µm. 
(C) Immunostaining against Sert (red) in sections from E16.5 embryos electroporated with 
Sert/EGFP (green) at E13.5 confirms ectopic expression of Sert in the targeted area. (D) The 
picture shows the optic chiasm region of E16.5 embryos electroporated with different plasmids 
at E13.5. In embryos electroporated with EGFP alone or with Sert/EGFP all targeted axons 
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cross the midline, contrasting with Zic2/EGFP or EphB1/EGFP electroporated embryos that 
show ipsi- and contralateral axons at the optic chiasm. Red arrows point to the ectopic 
ipsilateral projection. Red-dashed lines mark the midline. on, optic nerve; iot, ipsilateral optic 
tract; cot, contralateral optic tract. Scale bar: 500µm. 
 
 
SUPPLEMENTARY MATERIAL 
Supplementary Figure S1. (A) Detailed gene expression comparison of wildtype (WT) and 
Zic2 mutant (Kd) VT retinal segments. The different graphs show the normalized values 
obtained for each probe-set that showed a statistically significant change when comparing 
wildtype and Zic2 mutant VT segments. The microarray comparison was performed three times 
and each line in the graph represents an individual experiment. For Nedd9 data of two different 
probe-sets are represented in the same graph. Down-regulated probe-sets are shown in blue and 
up-regulated probe-sets in red. Sert showed the strongest down-regulation. Among the up-
regulated probe-sets, three corresponded to genes related to the eye lens: crystalline alpha B 
(Cryab, 4.41-fold), crystalline gamma N (Crygn, 4.40-fold) and lens intrinsic membrane protein 
2 (Lim2, 2.09-fold). These three proteins are highly expressed in the lens during and after eye 
development, but are not detected in the neural retina at E16.5 (Robinson & Overbeek, 1996). 
The lens and the ciliary body zone (CB) are physically attached structures, and molecular 
evidence supports a role for the lens in the early specification of the CB (Thut et al, 2001). 
Thus, we believe that the changes detected in Cryab, Crygn and Lim2 are related to the 
unknown role of Zic2 in the CB, where it is highly expressed at earlier stages of eye 
development (Herrera et al, 2003; Nagai et al, 1997).  
 
(B) Schematic representation of the genomic WT and the Zic2 knockdown (kd) alleles. The 
forth probe-set that showed a large increase (4.24-fold) was 1430350_at. This probe-set 
corresponds to the gene 2610035F20Rik, which is located 3.9 kb upstream of the Zic2 
transcriptional start site in the opposite direction to Zic2 transcription. The prominent presence 
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of this probe-set in this short list of significantly altered genes in Zic2kd/kd mice contributes to 
validate our analysis. As a result of the illegitimate homologous recombination that occurred 
during the generation of the Zic2 mutant mice, PGKneo and 622 bp of the 5′ homologous 
regions were inserted into the first intron in opposite direction to Zic2, producing the Zic2kd 
allele (Nagai et al, 2000). The 1430350_at: 2610035F20Rik transcript (represented by a dark 
blue line and dark blue arrow) that appears up-regulated in the array analysis is located at 3.9 kb 
from the transcriptional start site of Zic2 in a reverse direction to Zic2. Thus, it is likely that the 
presence of the neo basal promoter (PGK) up-regulates this transcript in the Zic2kd mice 
compared to the WT mice. However, since the probe-set used by Affymetrix to detect Zic2 
(1421301_at, represented by an orange line and orange arrow) in the gene-chip array is located 
in the 3´UTR region of the gene, this sequence is normally transcribed in the mutant and 
therefore there is no fold-change for 1421301_at when comparing WT and Zic2kd retinas using 
Affymetrix microarrays.  
 
Supplementary Figure S2. Ipsilateral RGCs from mutant mice lacking Sert show a “lack-
of-refinement” phenotype in the SC. (a, d) Schematic drawing that summarizes the 
experimental approach used to visualize the ipsilateral projection. Cholera-toxin subunit B 
conjugated to Alexa-Fluor 488 (green) was monocularly injected in P14 or P33 mice. In P33 
mice CTB-Alexa-Fluor 594 (red) was additionally injected in the other eye. One day after the 
injection, mice were sacrificed and sagittal sections of the colliculus ipsilateral to the CTB-488 
injected eye were analyzed. (b, c) Sagittal sections at the level of the SC indicated by the gray-
dashed line in P15 wildtype and Sert null mice respectively. (e, f) The pictures show sagittal 
sections of the SC of P34 wildtype and Sert null mice respectively. Gray-dashed lines indicate 
the level at which the section was performed. White arrows highlight the lack-of-refinement of 
the ipsilateral axons observed in Sert null mice. White dashed-circles mark the normal TZ of 
ipsilateral axons. r, rostral; c, caudal. Scale bars: 100µm. 
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Supplementary Figure S3. A model for the function of Zic2 in the retinofugal pathway. 
Zic2 specifies the ipsilateral identity by regulating the expression of EphB1 and Sert in 
ipsilateral but not in contralateral retinal ganglion cells. The EphB1 receptor is expressed when 
ipsilateral axons reach the optic chiasm midline, where it binds to its ligand ephrinB2. EphB1-
ephrinB2 interaction provokes the repulsive response of ipsilateral axons to avoid the midline. 
Once at the SC, all RGCs express 5HT1B receptors in the axon terminals. The 5HT1B receptor is 
negatively coupled to the adenylate cyclase 1 (AC1) via G-proteins. Activation of 5HT1B 
receptor by serotonin (5-HT) inhibits cAMP production and calcium entry in contralateral axon 
terminals, while retinal axons that express Sert (the ipsilateral axons) can internalize 
extracellular serotonin and relieve 5HT1B-mediated inhibition, producing cAMP. This would 
produce a discrepancy in the activity levels of the afferent retinal inputs, allowing eye-specific 
refinement/segregation.  R, rostral; C, caudal. 
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